Pages that link to "Q1149042"
Jump to navigation
Jump to search
The following pages link to cystinosis (Q1149042):
Displayed 50 items.
- cysteamine (Q617563) (← links)
- Abderhalden–Kaufmann–Lignac syndrome (Q4664900) (← links)
- Cystinosis: a review (Q26751225) (← links)
- Cystinosis: the evolution of a treatable disease (Q26863651) (← links)
- Cystagon (Q29005688) (← links)
- Procysbi (Q29006373) (← links)
- Cystinosis: practical tools for diagnosis and treatment (Q34467739) (← links)
- CET.IPS.FFCYST-500 (Q54809353) (← links)
- GM00008 (Q54835967) (← links)
- GM00018 (Q54835976) (← links)
- GM00020 (Q54835977) (← links)
- GM00046 (Q54836003) (← links)
- GM00090 (Q54836031) (← links)
- GM00093 (Q54836032) (← links)
- GM00304 (Q54836149) (← links)
- GM00378 (Q54836193) (← links)
- GM00379 (Q54836194) (← links)
- GM00489 (Q54836258) (← links)
- GM00706 (Q54836400) (← links)
- GM00760 (Q54836447) (← links)
- GM00804 (Q54836463) (← links)
- GM00908 (Q54836526) (← links)
- GM02066 (Q54837283) (← links)
- GM02894 (Q54837742) (← links)
- GM08761 (Q54843268) (← links)
- GM17885 (Q54849299) (← links)
- GM17886 (Q54849300) (← links)
- GM17888 (Q54849302) (← links)
- ocular cystinosis (Q55998570) (← links)
- cystinosis, nephropathic (Q55998573) (← links)
- Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis (Q61980455) (← links)
- Cure Cystinosis International Registry (Q63338656) (← links)
- Use of Cysteamine in the Treatment of Cystinosis (Q63573740) (← links)
- Stem Cell Gene Therapy for Cystinosis (Q63587132) (← links)
- Biomarker for Cystinosis Disease: BioCystinosis (Q63813263) (← links)
- N Acetyl Cysteine for Cystinosis Patients (Q63843221) (← links)
- CYSTEA-BONE Clinical Study (Q64171748) (← links)
- A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications (Q64351019) (← links)
- Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis (Q64637365) (← links)
- Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™ (Q64648188) (← links)
- Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) (Q64651641) (← links)
- Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis (Q64661174) (← links)
- Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis (Q64694860) (← links)
- The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients (Q65334998) (← links)
- Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis (Q65360259) (← links)
- Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis (Q65371387) (← links)
- Salivary Proteins in Disease and Health (Q66033672) (← links)
- The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study (Q66034288) (← links)
- Kidney Transplantation in Patients With Cystinosis (Q66035865) (← links)
- New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis (Q66039029) (← links)